HBM Holdings Independent Director Faces CSRC Probe; Board Affirms Normal Operations

Bulletin Express

05/13

HBM Holdings Limited announced that independent non-executive director Dr. Xiaoping Ye received a case-filing notice from the China Securities Regulatory Commission on 12 May 2026. The investigation concerns alleged violations of information-disclosure rules related to changes in the shareholding of Hangzhou Tigermed Consulting Co., Ltd.

Dr. Ye holds no management responsibilities within HBM Holdings and will cooperate fully with regulators. The board stated that the Group’s daily operations remain unaffected and pledged to release further updates as required.

Shareholders and potential investors are advised to exercise caution when dealing in the company’s shares. The announcement was signed by Chairman and Executive Director Dr. Jingsong Wang on 13 May 2026.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1143981327"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1143981327\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1143981327?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-13 12:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1143981327","market":"us","top_or_hot":-1,"title":"HBM Holdings Independent Director Faces CSRC Probe; Board Affirms Normal Operations","media":"Bulletin Express","content":"<p>HBM Holdings Limited announced that independent non-executive director Dr. Xiaoping Ye received a case-filing notice from the China Securities Regulatory Commission on 12 May 2026. The investigation concerns alleged violations of information-disclosure rules related to changes in the shareholding of Hangzhou Tigermed Consulting Co., Ltd.</p>\n<p>Dr. Ye holds no management responsibilities within HBM Holdings and will cooperate fully with regulators. The board stated that the Group’s daily operations remain unaffected and pledged to release further updates as required.</p>\n<p>Shareholders and potential investors are advised to exercise caution when dealing in the company’s shares. The announcement was signed by Chairman and Executive Director Dr. Jingsong Wang on 13 May 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HBM Holdings Independent Director Faces CSRC Probe; Board Affirms Normal Operations</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHBM Holdings Independent Director Faces CSRC Probe; Board Affirms Normal Operations\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-13 12:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>HBM Holdings Limited announced that independent non-executive director Dr. Xiaoping Ye received a case-filing notice from the China Securities Regulatory Commission on 12 May 2026. The investigation concerns alleged violations of information-disclosure rules related to changes in the shareholding of Hangzhou Tigermed Consulting Co., Ltd.</p>\n<p>Dr. Ye holds no management responsibilities within HBM Holdings and will cooperate fully with regulators. The board stated that the Group’s daily operations remain unaffected and pledged to release further updates as required.</p>\n<p>Shareholders and potential investors are advised to exercise caution when dealing in the company’s shares. The announcement was signed by Chairman and Executive Director Dr. Jingsong Wang on 13 May 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02142","symbol_name":"和铂医药-B","start_time":0,"source_url":"","article_id":"1143981327","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1143981327","pubTimestamp":1778646188,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"HBM Holdings Limited announced that independent non-executive director Dr. Xiaoping Ye received a case-filing notice from the China Securities Regulatory Commission on 12 May 2026. The investigation...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02142":"和铂医药-B"},"translate_title":"HBM Holdings独立董事面临证监会调查；董事会确认运营正常","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02142":1},"content_text":"HBM Holdings Limited announced that independent non-executive director Dr. Xiaoping Ye received a case-filing notice from the China Securities Regulatory Commission on 12 May 2026. The investigation concerns alleged violations of information-disclosure rules related to changes in the shareholding of Hangzhou Tigermed Consulting Co., Ltd.\nDr. Ye holds no management responsibilities within HBM Holdings and will cooperate fully with regulators. The board stated that the Group’s daily operations remain unaffected and pledged to release further updates as required.\nShareholders and potential investors are advised to exercise caution when dealing in the company’s shares. The announcement was signed by Chairman and Executive Director Dr. Jingsong Wang on 13 May 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"policyRegulatory,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}